Skip to content
PneumRx logo

PneumRx Alternatives & Competitors

12 companies similar to PneumRx — Innovative solutions for minimally invasive emphysema treatment with a pioneerin...

Companies similar to PneumRx

SuperDimension logo — alternative to PneumRx

SuperDimension

Pioneering the future of minimally-invasive pulmonology, enhancing early-stage diagnosis a...

Hanyu Medical logo — alternative to PneumRx

Hanyu Medical

Pioneering minimally invasive mitral valve repair solutions for effective heart disease tr...

Mirabilis Medical logo — alternative to PneumRx

Mirabilis Medical

Pioneering non-invasive solutions for treating uterine fibroids, empowering gynecologists...

TARIS logo — alternative to PneumRx

TARIS

Innovative therapies for challenging bladder conditions, with a tailored, extended-release...

Rival Readout

Competing with PneumRx? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Taurus Vascular logo — alternative to PneumRx

Taurus Vascular

Taurus Vascular is a medical device startup focused on transforming the standard of care f...

Polynova Cardiovascular logo — alternative to PneumRx

Polynova Cardiovascular

Innovative solutions for minimally invasive heart valve treatments using synthetic biomate...

Stimdia Medical Inc. logo — alternative to PneumRx

Stimdia Medical Inc.

Neuromodulation for Breathing.

Lungpacer Medical logo — alternative to PneumRx

Lungpacer Medical

Dedicated to natural breathing by empowering patients to wean off mechanical ventilation a...

Nuvaira, Inc. logo — alternative to PneumRx

Nuvaira, Inc.

Our dNerva® Lung Denervation System is an investigative COPD therapy that aims to preserve...

Suros Surgical Systems logo — alternative to PneumRx

Suros Surgical Systems

Pioneering compassionate, efficient, and minimally invasive tissue excision and biopsy for...

CircuLite logo — alternative to PneumRx

CircuLite

Innovating heart failure treatment with minimally-invasive micro-pumps for enhanced long-t...

PQ Bypass logo — alternative to PneumRx

PQ Bypass

Leading the charge in minimally-invasive treatments for long-segment peripheral artery dis...

About PneumRx

PneumRx, Inc. is a startup focusing on medical devices and dedicated to developing minimally invasive treatments for emphysema patients. Established in 2004 and based in Mountain View, California, the company has made significant strides in the biotechnology, healthcare, and medical devices industries.

Business keywords

PneumRx, Emphysema Treatment, Lung Volume Reduction, Minimally Invasive Procedures, Healthcare Innovation, Medical Technology, Startup, Mountain View, California, Pioneering Device, Lung Disease, Treatment Innovation

Frequently Asked Questions

Companies similar to PneumRx include SuperDimension, Hanyu Medical, Mirabilis Medical, TARIS, Taurus Vascular. They work in Health Care and Medical Devices and share PneumRx's focus on minimally invasive procedures, startup and medical technology.
Bounce Watch lists 12 companies that share PneumRx's industries and are closest to it in business tags, services, target customers, business model and size.
PneumRx, Inc. is a startup focusing on medical devices and dedicated to developing minimally invasive treatments for emphysema patients. Established in 2004 and based in Mountain View, California, the company has made significant strides in the biotechnology, healthcare, and medical devices industries.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around PneumRx: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at PneumRx on 11 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 16 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout